ESR1 - Zotta-A, Zaslona-Z, O'Neill-L.
Is citrate a critical signal in immunity and inflammation?
Journal of Cellular Signaling 2020, 1, 87-96.
https://doi.org/10.33696/Signaling.1.017
ESR1 - Zotta-A, [...], Zaslona-Z, O'Neill-L.
4-Octyl-Itaconate and Dimethyl Fumarate Inhibit COX2 Expression and Prostaglandin Production in Macrophages.
J. Immunol. 2021.
https://doi.org/10.4049/jimmunol.2100488
ESR2 - Georg P, […], Kostevc T, […], Sawitzki B.
Complement activation induces excessive T cell cytotoxicity in severe COVID-19.
Cell 2021.
doi not yet available
ESR3 - Fortunato-M, Morali-K, Passeri-L, Gregori-S.
Regulatory cell therapy in organ transplantation: achievements and open questions.
Frontiers in Immunology 23 February 2021.
https://doi.org/10.3389/fimmu.2021.641596
ESR4 - Gonzalez-Perez M., Tarjuelo-Sanchez R., Shor Boris, Nistal-Villan E, Ochando J.
The BCG Vaccine for COVID-19: First Verdict and Future Directions.
Frontiers in Immunology 2021.
https://doi.org/10.3389/fimmu.2021.632478
ESR4 - Lozano-Ojalvo D, […], Gonzalez-Perez M., et al.
Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naive and COVID-19 recovered individuals.
Cell reports 2021.
https://doi.org/10.1016/j.celrep.2021.109570
ESR4 - Borobia A, […], Gonzalez-Perez M. et al.
Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial .
The Lancet 2022.
https://doi.org/10.1016/S0140-6736(21)01420-3
ESR6 - Maaike Suuring and Aurélie Moreau.
Regulatory Macrophages and Tolerogenic Dendritic Cells in Myeloid Regulatory Cell-Based Therapies.
International journal of molecular science 2021.
https://doi.org/10.3390/ijms22157970
ESR13 - Morante Palacios-O, Fondelli-F, Ballestar-E, Martínez Cáceres-EM.
Tolerogenic Dendritic Cells in Autoimmunity and Inflammatory Diseases.
Trends Immunol. 2021.
https://doi.org/10.1016/j.it.2020.11.001
ESR13 - M. J. Mansilla, S. Presas-Rodríguez, A. Teniente-Serra, I. González-Larreategui, B. Quirant-Sánchez, F. Fondelli, N. Djedovic, D. Iwaszkiewicz-Grześ, K. Chwojnicki, Đ. Miljković, P. Trzonkowski, C. Ramo-Tello & E. M. Martínez-Cáceres.
Paving the way towards an effective treatment for multiple sclerosis: advances in cell therapy.
Cellular & Molecular Immunology 2021 18, 1353-1374.
https://doi.org/10.1038/s41423-020-00618-z
ESR13 - María José Mansilla, […], Fondelli F., […], Martinez Càceres E.
Transfection of Vitamin D3-Induced Tolerogenic Dendritic Cells for the Silencing of Potential Tolerogenic Genes. Identification of CSF1R-CSF1 Signaling as a Glycolytic Regulator.
Int. J. Mol. Sci. 2021.
https://doi.org/10.3390/ijms22147363
ESR13 - Quirant-Sánchez B., […], Fondelli F., […], Martinez Càceres E.
TCombined Therapy of Vitamin D3-Tolerogenic Dendritic Cells and Interferon-β in a Preclinical Model of Multiple Sclerosis.
Biomedicines 2021.
https://doi.org/10.3390/biomedicines9121758
ESR14 - Hutchinson-JA, […], Cordero-L et al.
Virus-specific memory T cell responses unmasked by immune checkpoint blockade cause hepatitis.
Nature Communications 2021.
https://doi.org/10.1038/s41467-021-21572-y
ESR14 - Hannah-Lou Schilling, […], Cordero-L et al.
Development of a Flow Cytometry Assay to Predict Immune Checkpoint Blockade-Related Complications.
Frontiers of Immunology 2021.
https://doi.org/10.3389/fimmu.2021.765644
An important work resulting from “The ONE Study” project and INsTRuCT partners' previous collaboration
The Lancet: Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials
Prof Birgit Sawitzki et al.
Free download of the article: https://authors.elsevier.com/c/1b68ZV-4XAjTj